521
Views
39
CrossRef citations to date
0
Altmetric
Reviews

Targeting the MET oncogene in cancer and metastases

, MD PhD, , PhD & , MD PhD
Pages 1381-1394 | Published online: 26 Sep 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mary E Olanich & Frederic G Barr. (2013) A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. Expert Opinion on Therapeutic Targets 17:5, pages 607-623.
Read now
Massimo Broggini, Marina Chiara Garassino & Giovanna Damia. (2013) Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer. Cancer Management and Research 5, pages 15-20.
Read now

Articles from other publishers (37)

John Maringa Githaka, Leila Pirayeshfard & Ing Swie Goping. (2023) Cancer invasion and metastasis: Insights from murine pubertal mammary gland morphogenesis. Biochimica et Biophysica Acta (BBA) - General Subjects 1867:8, pages 130375.
Crossref
Giulia M. Stella, Caterina Marchiò, Elia Bari, Ilaria Ferrarotti, Francesco R. Bertuccio, Antonella Di Gennaro, David Michael Abbott, Paola Putignano, Ilaria Campo, Maria Luisa Torre & Angelo G. Corsico. (2023) The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints. International Journal of Molecular Sciences 24:4, pages 3496.
Crossref
Lin Wang, Xueting Wang, Tong Wang, Yingping Zhuang & Guan Wang. (2021) Multi-omics analysis defines 5-fluorouracil drug resistance in 3D HeLa carcinoma cell model. Bioresources and Bioprocessing 8:1.
Crossref
Wahaj Alnefaie. 2021. Role of Exosomes in Biological Communication Systems. Role of Exosomes in Biological Communication Systems 277 292 .
Shainan Hora, Amit Kumar Pandey & Sudhakar Jha. 2018. Neoplasm. Neoplasm.
Carmen Rodríguez-Cerdeira, Alberto Molares-Vila, Miguel Carnero-Gregorio & Alberte Corbalán-Rivas. (2018) Recent advances in melanoma research via “omics” platforms. Journal of Proteomics 188, pages 152-166.
Crossref
Meysam Yousefi, Tayyeb Bahrami, Arash Salmaninejad, Rahim Nosrati, Parisa Ghaffari & Seyed H. Ghaffari. (2017) Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options. Cellular Oncology 40:5, pages 419-441.
Crossref
Adam Siddiqui-Jain, Jacob P. Hoj, J. Blade Hargiss, Taylor H. Hoj, Carter J. Payne, Collin A. Ritchie, Steven R. Herron, Colette Quinn, Jeffrey T. Schuler & Marc D.H. Hansen. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms. Bioorganic & Medicinal Chemistry Letters 27:17, pages 3992-4000.
Crossref
Jordi Rodon, Sophie Postel-Vinay, Antoine Hollebecque, Paolo Nuciforo, Analia Azaro, Valérie Cattan, Lucie Marfai, Isabelle Sudey, Karl Brendel, Audrey Delmas, Stéphanie Malasse & Jean-Charles Soria. (2017) First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours. European Journal of Cancer 81, pages 142-150.
Crossref
Giulia M. Stella, Alessandra Gentile, Alice Balderacchi, Federica Meloni, Melissa Milan & Silvia Benvenuti. (2016) Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer. Journal of Translational Medicine 14:1.
Crossref
Taylor H. Hoj, Ryan J. Robinson, Jason C. Burton, Rachel A. Densley-Ure, Tyler V. Olson, Logan K. Williams, Lori Coward, Greg Gorman & Marc D.H. Hansen. (2016) Small Molecules Revealed in a Screen Targeting Epithelial Scattering Are Inhibitors of Microtubule Polymerization. SLAS Discovery 21:7, pages 671-679.
Crossref
Ying Wang, Zhengsheng Zhan, Xifei Jiang, Xia Peng, Yanyan Shen, Fang Chen, Yinchun Ji, Weiren Liu, Yinghong Shi, Wenhu Duan, Jian Ding, Jing Ai & Meiyu Geng. (2016) Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities. Oncotarget 7:25, pages 38091-38104.
Crossref
Zhengsheng Zhan, Xia Peng, Qiufeng Liu, Fang Chen, Yinchun Ji, Shanyan Yao, Yong Xi, Yipeng Lin, Tiantian Chen, Yechun Xu, Jing Ai, Meiyu Geng & Wenhu Duan. (2016) Discovery of 6-(difluoro(6-(4-fluorophenyl)-[1,2,4]triazolo[4,3- b ][1,2,4]triazin-3-yl)methyl)quinoline as a highly potent and selective c-Met inhibitor. European Journal of Medicinal Chemistry 116, pages 239-251.
Crossref
Arturo Loaiza-Bonilla, Emma E Furth & Jennifer JD Morrissette. (2015) Next-generation sequencing and personalized genomic medicine in hepatobiliary malignancies. Hepatic Oncology 2:4, pages 359-370.
Crossref
Zhiming Wu, Huangen Wang, Sunyang Fang & Chaoyang Xu. (2015) MiR-449c inhibits gastric carcinoma growth. Life Sciences 137, pages 14-19.
Crossref
Jayoung Song, Yongseok Kwon, Sanghee Kim & Sang Kook Lee. (2015) Antitumor Activity of Phenanthroindolizidine Alkaloids Is Associated with Negative Regulation of Met Endosomal Signaling in Renal Cancer Cells. Chemistry & Biology 22:4, pages 504-515.
Crossref
Jeffrey S. Ross, Kai Wang, Laurie Gay, Geoff A. Otto, Emily White, Kiel Iwanik, Gary Palmer, Roman Yelensky, Doron M. Lipson, Juliann Chmielecki, Rachel L. Erlich, Andrew N. Rankin, Siraj M. Ali, Julia A. Elvin, Deborah Morosini, Vincent A. Miller & Philip J. Stephens. (2015) Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site. JAMA Oncology 1:1, pages 40.
Crossref
Rosaria Gangemi, Adriana Amaro, Alice Gino, Gaia Barisione, Marina Fabbi, Ulrich Pfeffer, Antonella Brizzolara, Paola Queirolo, Sandra Salvi, Simona Boccardo, Marina Gualco, Francesco Spagnolo, Martine J. Jager, Carlo Mosci, Armando Rossello & Silvano Ferrini. (2014) ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion. Pigment Cell & Melanoma Research 27:6, pages 1138-1148.
Crossref
Timothy G. Whitsett, Shannon P. Fortin Ensign, Harshil D. Dhruv, Landon J. Inge, Paul Kurywchak, Kerri K. Wolf, Janine LoBello, Christopher B. Kingsley, Jeffrey W. Allen, Glen J. Weiss & Nhan L. Tran. (2014) FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion. Clinical & Experimental Metastasis 31:6, pages 613-623.
Crossref
Federica Morani, Rossella Titone, Loredana Pagano, Alessandra Galetto, Oscar Alabiso, Gianluca Aimaretti & Ciro Isidoro. (2014) Autophagy and thyroid carcinogenesis: genetic and epigenetic links. Endocrine-Related Cancer 21:1, pages R13-R29.
Crossref
Jinlu Dai, Honglai Zhang, Andreas Karatsinides, Jill M. Keller, Kenneth M. Kozloff, Dana T. Aftab, Frauke Schimmoller & Evan T. Keller. (2014) Cabozantinib Inhibits Prostate Cancer Growth and Prevents Tumor-Induced Bone Lesions. Clinical Cancer Research 20:3, pages 617-630.
Crossref
Michaela Medová, Benoît Pochon, Bruno Streit, Wieslawa Blank-Liss, Paola Francica, Deborah Stroka, Adrian Keogh, Daniel M. Aebersold, Andree Blaukat, Friedhelm Bladt & Yitzhak Zimmer. (2013) The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants. Molecular Cancer Therapeutics 12:11, pages 2415-2424.
Crossref
Laurent Raibaut, Jérome Vicogne, Bérénice Leclercq, Hervé Drobecq, Rémi Desmet & Oleg Melnyk. (2013) Total synthesis of biotinylated N domain of human hepatocyte growth factor. Bioorganic & Medicinal Chemistry 21:12, pages 3486-3494.
Crossref
HAIZHONG YU, JIANFEN YUAN, CHUNHONG XIAO & YI QIN. (2013) Integrative genomic analyses of recepteur d’origine nantais and its prognostic value in cancer. International Journal of Molecular Medicine 31:5, pages 1248-1254.
Crossref
Michele Biscuola, Koen Van de Vijver, María Ángeles Castilla, Laura Romero-Pérez, María Ángeles López-García, Juan Díaz-Martín, Xavier Matias-Guiu, Esther Oliva & José Palacios Calvo. (2013) Oncogene alterations in endometrial carcinosarcomas. Human Pathology 44:5, pages 852-859.
Crossref
Giulia M Stella, Maurizio Luisetti, Ernesto Pozzi & Paolo M Comoglio. (2013) Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. The Lancet Respiratory Medicine 1:3, pages 251-261.
Crossref
Magali Humbert, Michaela Medová, Daniel M. Aebersold, Andree Blaukat, Friedhelm Bladt, Martin F. Fey, Yitzhak Zimmer & Mario P. Tschan. (2013) Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells. Biochemical and Biophysical Research Communications 431:2, pages 264-269.
Crossref
A. Fasolo, C. Sessa, L. Gianni & M. Broggini. (2013) Seminars in clinical pharmacology: an introduction to MET inhibitors for the medical oncologist. Annals of Oncology 24:1, pages 14-20.
Crossref
S. Mizuno & T. Nakamura. 2013. Brenner's Encyclopedia of Genetics. Brenner's Encyclopedia of Genetics 371 374 .
Giulia Maria Stella, Rebecca Senetta, Adele Cassenti, Margherita Ronco & Paola Cassoni. (2012) Cancers of unknown primary origin: current perspectives and future therapeutic strategies. Journal of Translational Medicine 10:1.
Crossref
Farbod Shojaei, Brett H. Simmons, Joseph H. Lee, Patrick B. Lappin & James G. Christensen. (2012) HGF/c-Met pathway is one of the mediators of sunitinib-induced tumor cell type-dependent metastasis. Cancer Letters 320:1, pages 48-55.
Crossref
Héctor Peinado, Maša Alečković, Simon Lavotshkin, Irina Matei, Bruno Costa-Silva, Gema Moreno-Bueno, Marta Hergueta-Redondo, Caitlin Williams, Guillermo García-Santos, Cyrus M Ghajar, Ayuko Nitadori-Hoshino, Caitlin Hoffman, Karen Badal, Benjamin A Garcia, Margaret K Callahan, Jianda Yuan, Vilma R Martins, Johan Skog, Rosandra N Kaplan, Mary S Brady, Jedd D Wolchok, Paul B Chapman, Yibin Kang, Jacqueline Bromberg & David Lyden. (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine 18:6, pages 883-891.
Crossref
Kanwal P. Raghav, Wenting Wang, Shuying Liu, Mariana Chavez-MacGregor, Xiaolong Meng, Gabriel N. Hortobagyi, Gordon B. Mills, Funda Meric-Bernstam, George R. BlumenscheinJrJr & Ana M. Gonzalez-Angulo. (2012) cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes. Clinical Cancer Research 18:8, pages 2269-2277.
Crossref
Sameer A. Greenall, Ermanno Gherardi, Zhanqi Liu, Jacqueline F. Donoghue, Angela A. Vitali, Qian Li, Roger Murphy, Luisa Iamele, Andrew M. Scott & Terrance G. Johns. (2012) Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET. PLoS ONE 7:4, pages e34658.
Crossref
Robert KraftAllon KahnJosé L. Medina-FrancoMikayla L. OrlowskiCayla BaynesFabian López-VallejoKobus BarnardGerald M. Maggiora & Linda L. Restifo. (2012) A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions. Disease Models & Mechanisms.
Crossref
Jens U. Marquardt, Peter R. Galle & Andreas Teufel. (2012) Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies. Journal of Hepatology 56:1, pages 267-275.
Crossref
Elisabetta Vergani, Viviana Vallacchi, Simona Frigerio, Paola Deho, Piera Mondellini, Paola Perego, Giuliana Cassinelli, Cinzia Lanzi, Maria Adele Testi, Licia Rivoltini, Italia Bongarzone & Monica Rodolfo. (2011) Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032. Neoplasia 13:12, pages 1132-IN17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.